Anti-α synuclein binding molecules
US9580493B2 · kind B2 · utility
8Cited by
28References
58Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 22, 2012 |
| Grant date | Feb 28, 2017 |
| Priority date | — |
| Expiry date | Mar 1, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2835
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are anti-human α-synuclein-specific binding molecules, e.g., antibodies or antigen-binding fragments, variants or derivatives thereof, as methods related thereto. Further provided are anti-human α-synuclein binding molecules which bind to specific N-terminal and C-terminal epitopes on human α-synuclein. The binding molecules described herein can be used in pharmaceutical and diagnostic compositions for α-synuclein targeted immunotherapy and diagnosis, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.